MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer

References

• Labbé M, Hoey C, Ray J, et al. microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation. Mol Cancer. 2020;19(1):1–18.
   PubMed Web of Science ®Google Scholar
• Ozen M, Karatas OF, Gulluoglu S, et al. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest. 2015;33(6):251–258.
   PubMed Web of Science ®Google Scholar
• Trivedi P, Kumar RK, Iyer A, et al. Targeting phospholipase D4 attenuates kidney fibrosis. J Am Soc Nephrol. 2017;28(12):3579–3589.
   PubMed Web of Science ®Google Scholar
• Uchida N, Okamura S, Nagamachi Y, et al. Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol. 1997;123(5):280–285.
   PubMed Web of Science ®Google Scholar
• Foster DA, Xu L. Phospholipase D in cell proliferation and cancer11national cancer institute, and the institutional support from the research centers in minority institutions (RCMI) program of the NIH. Mol Cancer Res. 2003;1(11):789–800.
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang X, Li H, et al. Phospholipase D as a key modulator of cancer progression. Biol Rev. 2020;95(4):911–935.
   PubMed Web of Science ®Google Scholar
• Baltimore D, Boldin MP, O’connell RM, et al. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9(8):839.
   PubMed Web of Science ®Google Scholar
• Abd-Aziz N, Kamaruzman NI, Poh CL. Development of microRNAs as potential therapeutics against cancer. Journal of Oncology. 2020;2020:8029721.
   PubMed Web of Science ®Google Scholar
• Sachdeva M, Mo -Y-Y. miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res. 2010;2(2):170–180.
   PubMed Web of Science ®Google Scholar
• Shi XB, Tepper CG, White RW. MicroRNAs and prostate cancer. J Cell Mol Med. 2008;12(5a)(5a):1456–1465.
   Web of Science ®Google Scholar
• Sun Y, Chen G, He J, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;12(1):325–340.
   PubMed Web of Science ®Google Scholar
• Ding X, Xu X, He XF, et al. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Bioengineered. 2021;12(1):803–814.
   PubMed Web of Science ®Google Scholar
• Pan D, Jia Z, Li W, et al. The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells. Int J Oncol. 2019;54(6):1955–1968.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu X, Zhang G, et al. Knockdown THOC2 suppresses the proliferation and invasion of melanoma. Bioengineered. 2019;10(1):635–645.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou K, Ma L, et al. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered. 2020;11(1):219–228.
   PubMed Web of Science ®Google Scholar
• Riaz F, Chen Q, Lu K, et al. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. Journal of Cellular and Molecular Medicine. 2021;25(8):4073–4087.
   PubMed Web of Science ®Google Scholar
• Zhang GM, Bao CY, Wan FN, et al. MicroRNA-302a suppresses tumor cell proliferation by inhibiting AKT in prostate cancer. PloS One. 2015;10(4):e0124410.
   PubMed Web of Science ®Google Scholar
• Mu L, Yang F, Guo D, et al. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p. Bioengineered. 2020;11(1):472–483.
   PubMed Web of Science ®Google Scholar
• Printz C. Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor. Cancer. 2020;126(17):3893–3894.
   PubMed Web of Science ®Google Scholar
• Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–89.
   PubMedGoogle Scholar
• Shang W, Chen X, Nie L, et al. MiR199b suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in prostate cancer cells. Int J Mol Sci. 2013;14(4):8422–8436.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen CJ, Lin ZY, et al. Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway. Biochem Cell Biol. 2020;98(3):396–404.
   PubMed Web of Science ®Google Scholar
• Pan Y, Ye C, Tian Q, et al. miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade. Oncol Lett. 2018;15(4):4337–4343.
   PubMed Web of Science ®Google Scholar
• Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690–2695.
   PubMed Web of Science ®Google Scholar
• Chiyomaru T, Enokida H, Tatarano S, et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010;102(5):883–891.
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and −145 in colon cancer. DNA Cell Biol. 2007;26(5):311–320.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu J. Prognostic role of microRNA-145 in prostate cancer: a systems review and meta-analysis. Prostate Int. 2015;3(3):71–74.
   PubMed Web of Science ®Google Scholar
• Chua FY, Adams BD. Androgen receptor and miR-206 regulation in prostate cancer. Transcription, 8(5):313–327. DOI: 10.1080/21541264.2017.1322668
   Google Scholar
• Jones DZ, Schmidt ML, Suman S, et al. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. BMC Cancer. 2018;18(1):421.
   PubMed Web of Science ®Google Scholar
• Lei C, Du F, Sun L, et al. miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017;8(10):e3101–e3101.
   PubMed Web of Science ®Google Scholar
• Zhou K, Song B, Wei M, et al. MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the ANGPT2/NOD_LIKE_RECEPTOR axis. Cancer Cell Int. 2020;20(1):416.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhang C, Zhang J, et al. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression. Int J Oncol. 2017;50(5):1701–1710.
   PubMed Web of Science ®Google Scholar
• Peng X, Frohman MA. Mammalian phospholipase D physiological and pathological roles. Acta Physiol (Oxf). 2012;204(2):219–226.
   PubMed Web of Science ®Google Scholar
• Tang W, Liang R, Duan Y, et al. PLD1 overexpression promotes invasion and migration and function as a risk factor for Chinese glioma patients. Oncotarget. 2017;8(34):57039–57046.
   PubMedGoogle Scholar
• Noble AR, Maitland NJ, Berney DM, et al. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation. Br J Cancer. 2018;118(2):189–199.
   PubMed Web of Science ®Google Scholar
• Xu M, Li J, Wang X, et al. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop. Cell Death Dis. 2018;9(2):209.
   PubMed Web of Science ®Google Scholar
• Bucay N, Bhagirath D, Sekhon K, et al. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Cell Death Differ. 2017;24(7):1263–1274.
   PubMed Web of Science ®Google Scholar